Akebia Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Akebia Therapeutics | 8-K: Akebia Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
Akebia Therapeutics | 8-K: Current report
Akebia Therapeutics | 8-K: Current report
Akebia Therapeutics | 8-K: Current report
Akebia Therapeutics | 8-K: Akebia Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
Akebia Therapeutics | DEF 14A: Definitive information statements
Akebia Therapeutics | DEFA14A: Others
Akebia Therapeutics | 8-K: Current report
Akebia Therapeutics | 8-K: Current report
Akebia Therapeutics | 8-K: Current report
Akebia Therapeutics | 8-K: Current report
Akebia Therapeutics | 8-K: Akebia Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
Akebia Therapeutics | 8-K: Current report
Akebia Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Akebia Therapeutics | 8-K: Current report
Akebia Therapeutics | 8-K: Current report
Akebia Therapeutics | 8-K: Current report
Akebia Therapeutics | 8-K: Current report
Akebia Therapeutics | 8-K: Current report
No Data
No Data